IMAC Holdings Inc
I020
Company Profile
Business description
IMAC Holdings Inc is engaged in providing services related to proteomic products that identify and support oncology clinical treatment decisions and biopharmaceutical drug development. The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, located in a single geographic location, the United States.
Contact
3401 Mallory Lane
Suite 100
FranklinTN37067
USAT: +1 303 898-5896
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
15
Stocks News & Analysis
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Proposed price regulation impacts our fair value.
stocks
Our top ASX picks in every sector
These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks
Tesla: Shares fall as deliveries come in below consensus
Long-term growth less reliant on auto sales.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,165.70 | 2.00 | 0.02% |
| CAC 40 | 8,272.15 | 363.41 | 4.60% |
| DAX 40 | 24,017.31 | 1,095.72 | 4.78% |
| Dow JONES (US) | 47,912.97 | 1,328.51 | 2.85% |
| FTSE 100 | 10,620.36 | 271.57 | 2.62% |
| HKSE | 25,893.02 | 776.49 | 3.09% |
| NASDAQ | 22,687.83 | 669.98 | 3.04% |
| Nikkei 225 | 56,308.42 | 2,878.86 | 5.39% |
| NZX 50 Index | 13,253.94 | 184.28 | 1.41% |
| S&P 500 | 6,776.33 | 159.48 | 2.41% |
| S&P/ASX 200 | 8,951.80 | 21.00 | -0.23% |
| SSE Composite Index | 3,995.00 | 104.83 | 2.69% |